Key Insights
The Europe Pharmaceutical Glass Vials and Ampoules Market is projected to experience robust growth, driven by the increasing demand for sterile drug packaging and advancements in pharmaceutical formulations. The market size for 0.8 Million Euros in 2025 is anticipated to expand significantly, fueled by a CAGR of 5.42% over the forecast period of 2025-2033. This growth is underpinned by several key drivers, including the expanding biopharmaceutical sector, the rising prevalence of chronic diseases necessitating advanced drug delivery systems, and stringent regulatory requirements for high-quality pharmaceutical packaging. The demand for glass vials and ampoules is particularly pronounced in the development and commercialization of biologics and personalized medicines, where product integrity and sterility are paramount. Furthermore, the ongoing innovation in glass formulations and manufacturing technologies, leading to enhanced product safety and functionality, also contributes positively to market expansion. The market is segmented by product type, with vials and ampoules being the primary categories, both playing crucial roles in drug packaging and administration.
Europe Pharmaceutical Glass Vials And Ampoules Market Market Size (In Million)
While the market presents a promising outlook, certain restraints could influence its trajectory. The increasing adoption of alternative packaging materials, such as specialized plastics and pre-filled syringes, poses a competitive challenge. Moreover, fluctuations in raw material prices, particularly for high-purity glass, and the complex regulatory landscape governing pharmaceutical packaging in Europe can impact manufacturing costs and market entry. However, the inherent advantages of glass, including its inertness, impermeability, and superior barrier properties, continue to make it the preferred choice for many high-value pharmaceuticals. Key players in the European market are focusing on strategic collaborations, mergers, and acquisitions, alongside investments in research and development to enhance their product offerings and expand their manufacturing capabilities, thereby solidifying their market positions. The heat map analysis indicates a concentrated market with significant activity from established players, suggesting a competitive yet growing environment.
Europe Pharmaceutical Glass Vials And Ampoules Market Company Market Share
Europe Pharmaceutical Glass Vials and Ampoules Market: In-Depth Analysis and Future Outlook (2019–2033)
This comprehensive market research report offers an in-depth analysis of the Europe Pharmaceutical Glass Vials and Ampoules Market. It provides critical insights into pharmaceutical primary packaging trends, drug delivery systems, and the biopharmaceutical packaging sector across key European countries. Utilizing the latest market data, this report covers the study period 2019–2033, with a base year of 2025 and an estimated year of 2025, followed by a detailed forecast period of 2025–2033 and a historical period of 2019–2024. Our analysis focuses on understanding market dynamics, growth drivers, challenges, and opportunities to equip stakeholders with actionable intelligence for strategic decision-making. The report delves into segments including pharmaceutical vials, pharmaceutical ampoules, and geographical markets such as Germany pharmaceutical glass vials and ampoules market, Italy pharmaceutical glass vials and ampoules market, France pharmaceutical glass vials and ampoules market, United Kingdom pharmaceutical glass vials and ampoules market, and Spain pharmaceutical glass vials and ampoules market.
Europe Pharmaceutical Glass Vials And Ampoules Market Market Concentration & Innovation
The Europe Pharmaceutical Glass Vials and Ampoules Market is characterized by a moderate to high level of market concentration, with a few prominent players holding significant market share. Innovation is a key differentiator, driven by the stringent demands of the pharmaceutical industry for enhanced product safety, efficacy, and patient compliance. Companies are investing heavily in advanced manufacturing technologies to improve the quality and functionality of glass vials and ampoules. This includes developing specialized coatings, enhanced breakage resistance, and solutions for sensitive drug formulations. Regulatory frameworks, such as those from the European Medicines Agency (EMA), play a crucial role in shaping innovation by setting high standards for pharmaceutical packaging materials. Product substitutes, primarily plastic containers, are present but face scrutiny for certain high-value or sensitive drug applications where glass maintains a superior barrier property. End-user trends indicate a growing preference for pre-filled syringes and complex injectable drug packaging, which indirectly influences demand for specific vial and ampoule configurations. Mergers and acquisitions (M&A) are significant activities, consolidating the market and enhancing the capabilities of leading companies. For instance, the Gerresheimer AG acquisition of Bormioli Pharma Group with an enterprise value of approximately USD 883.24 million signifies a major consolidation trend aimed at strengthening market presence and expanding product portfolios.
Europe Pharmaceutical Glass Vials And Ampoules Market Industry Trends & Insights
The Europe Pharmaceutical Glass Vials and Ampoules Market is experiencing robust growth, propelled by several interconnected industry trends. The increasing prevalence of chronic diseases globally fuels the demand for pharmaceutical drugs, particularly injectables, which directly translate into a higher need for high-quality glass vials and ampoules. Furthermore, the advancement of biopharmaceuticals and novel therapeutic modalities, such as biologics and gene therapies, necessitates specialized primary packaging that can maintain drug stability and prevent contamination. Glass, with its inertness and excellent barrier properties, remains the preferred material for these critical applications.
Technological disruptions are continuously shaping the market. Manufacturers are adopting advanced forming, annealing, and inspection technologies to produce vials and ampoules with tighter tolerances, improved dimensional stability, and reduced defect rates. The integration of smart packaging solutions, including serialization and track-and-trace capabilities, is also gaining traction to combat counterfeiting and enhance supply chain transparency. Consumer preferences, influenced by patient safety and convenience, are driving the development of user-friendly packaging designs. This includes features like easy-open ampoules and vials designed for compatibility with automated drug delivery systems.
The competitive dynamics within the market are intense, with key players focusing on product differentiation, geographical expansion, and strategic partnerships. The CAGR for the Europe Pharmaceutical Glass Vials and Ampoules Market is projected to be substantial, reflecting the sustained demand from the pharmaceutical sector. Market penetration of advanced packaging solutions is steadily increasing as pharmaceutical companies prioritize the integrity and safety of their drug products. The emphasis on sustainability is also becoming a more significant factor, with manufacturers exploring recycled glass options and energy-efficient production processes. The growing pipeline of parenteral drugs, coupled with the aging population and increased healthcare spending across Europe, are fundamental growth drivers, underpinning the market's positive trajectory. The ongoing shift towards specialty pharmaceuticals and personalized medicine further amplifies the need for sophisticated and reliable primary packaging solutions.
Dominant Markets & Segments in Europe Pharmaceutical Glass Vials And Ampoules Market
The Europe Pharmaceutical Glass Vials and Ampoules Market exhibits distinct regional and product segment dominance.
Dominant Regions:
Germany Pharmaceutical Glass Vials and Ampoules Market: Germany stands out as a dominant force within the European market.
- Economic Policies: Favorable industrial policies and robust economic growth in Germany provide a strong foundation for the pharmaceutical industry and its packaging suppliers.
- Infrastructure: The country boasts world-class logistics and research infrastructure, facilitating efficient production and distribution of pharmaceutical packaging.
- Research & Development: Significant investment in pharmaceutical R&D, particularly in areas like oncology and biologics, drives demand for high-quality glass vials and ampoules.
- Leading Manufacturers: The presence of major pharmaceutical packaging manufacturers headquartered or with substantial operations in Germany contributes to its market leadership.
Italy Pharmaceutical Glass Vials and Ampoules Market: Italy is another significant player, with a strong heritage in glass manufacturing.
- Specialized Manufacturing: A concentration of companies with expertise in producing high-quality pharmaceutical glass packaging.
- Export Hub: Italy serves as a crucial export hub for pharmaceutical glass products, supplying markets across Europe and beyond.
- Investment in Technology: Continuous investment in advanced manufacturing techniques to meet evolving industry standards.
France Pharmaceutical Glass Vials and Ampoules Market: France contributes significantly to the market, particularly with its focus on innovative packaging solutions.
- Biopharmaceutical Sector Growth: A thriving biopharmaceutical sector, with a strong pipeline of injectable drugs, fuels demand.
- Technological Advancements: Companies in France are at the forefront of developing specialized treatments for vials, such as siliconization, enhancing product functionality.
Dominant Segments:
Vials: The pharmaceutical vials segment currently holds the largest market share and is projected to continue its dominance.
- Broad Application Range: Vials are extensively used for a wide array of pharmaceutical products, including vaccines, antibiotics, chemotherapy drugs, and parenteral nutrition solutions.
- Increasing Demand for Injectables: The overall growth in the injectable drug market directly benefits the vials segment.
- Pre-filled Vial Systems: The trend towards pre-filled vials for greater convenience and reduced dosing errors further boosts demand.
Ampoules: While smaller in market share compared to vials, the ampoule segment is experiencing steady growth.
- Sterility and Single-Dose Applications: Ampoules are primarily used for sterile, single-dose medications where absolute integrity is paramount, such as highly potent drugs and sensitive biologicals.
- Innovation in Designs: Development of easier-to-open and safer ampoule designs is enhancing their appeal.
The strong performance of Germany, Italy, and France, coupled with the enduring demand for pharmaceutical vials, underpins the overall growth and structure of the Europe Pharmaceutical Glass Vials and Ampoules Market.
Europe Pharmaceutical Glass Vials And Ampoules Market Product Developments
Recent product developments in the Europe Pharmaceutical Glass Vials and Ampoules Market are focused on enhancing functionality, safety, and compatibility with advanced drug formulations. Manufacturers are innovating in areas such as Type I borosilicate glass, renowned for its exceptional chemical resistance and thermal stability, making it ideal for sensitive and high-potency drugs. Advancements in siliconization techniques, as exemplified by SGD Pharma's new siliconisation operation, improve internal lubricity, reduce drug adsorption, and enhance the smooth functioning of stoppers and plungers. This is crucial for complex biologics and parenteral nutrition. Furthermore, there is a growing emphasis on container closure integrity (CCI), with developments aimed at ensuring robust sealing to prevent microbial ingress and maintain drug sterility throughout the product lifecycle. The development of specialized vials for novel therapeutic areas like cell and gene therapies, which often require specific environmental controls and handling, is also a significant trend, driving demand for highly customized and advanced glass packaging solutions.
Report Scope & Segmentation Analysis
This report provides a granular analysis of the Europe Pharmaceutical Glass Vials and Ampoules Market. The segmentation analysis covers key areas essential for understanding market dynamics and future potential.
- Product Type: Vials: This segment encompasses all types of pharmaceutical vials, including serum vials, lyophilization vials, and vials for specific drug applications. Projections indicate sustained high demand driven by the injectable drug market, with growth expected to be robust. Market sizes are substantial, reflecting their widespread use across various therapeutic classes.
- Product Type: Ampoules: This segment includes various glass ampoules designed for single-dose parenteral administration. While a smaller segment than vials, it is characterized by its critical role in packaging sterile, sensitive medications. Growth projections are steady, driven by specialized pharmaceutical applications.
- Geography: Germany: The German market is a significant contributor, characterized by a strong manufacturing base and high R&D investment in the pharmaceutical sector. Market size is considerable, with steady growth expected due to its established pharmaceutical industry.
- Geography: Italy: Italy presents a strong market with a rich history in glass manufacturing, focusing on quality and specialized production. Market size is substantial, with growth supported by export activities and technological advancements.
- Geography: France: The French market shows promising growth, particularly in the biopharmaceutical sector, driving demand for advanced packaging solutions. Market size is significant and expected to expand with the rise of novel therapeutics.
- Geography: United Kingdom: The UK market is a key consumer, influenced by its advanced healthcare system and pharmaceutical research capabilities. Market size is substantial, with growth tied to the pharmaceutical pipeline and regulatory landscape.
- Geography: Spain: Spain represents a growing market within Europe, with increasing pharmaceutical production and demand for primary packaging. Market size is moderate but shows positive growth trends.
Key Drivers of Europe Pharmaceutical Glass Vials And Ampoules Market Growth
The Europe Pharmaceutical Glass Vials and Ampoules Market is propelled by several critical growth drivers. The ever-increasing global demand for pharmaceuticals, especially injectable drugs for chronic diseases and emerging therapeutic areas like oncology and biologics, is a primary catalyst. Advancements in drug formulations, particularly complex biologics and gene therapies, necessitate the superior inertness and barrier properties offered by glass packaging to maintain drug stability and prevent degradation. Regulatory stringent requirements for drug safety and sterility further favor glass over alternative materials for many critical applications. The growth of the biopharmaceutical sector in Europe, with its strong R&D pipeline, directly translates into increased demand for high-quality pharmaceutical glass vials and ampoules. Furthermore, the trend towards pre-filled and ready-to-use drug delivery systems enhances the demand for precisely manufactured vials and ampoules that integrate seamlessly into these advanced systems.
Challenges in the Europe Pharmaceutical Glass Vials And Ampoules Market Sector
Despite its growth trajectory, the Europe Pharmaceutical Glass Vials and Ampoules Market faces several challenges. Increasing raw material costs, particularly for high-quality glass and associated components, can impact profit margins. Stringent regulatory compliance, while driving quality, also adds complexity and cost to manufacturing processes. The threat of product substitution from plastics, especially for less sensitive applications, remains a concern, necessitating continuous innovation in glass packaging to demonstrate its value proposition. Supply chain disruptions, as witnessed in recent global events, can affect the availability of raw materials and finished products, leading to production delays and increased lead times. Intense competition among established players and emerging manufacturers can put pressure on pricing and market share. Furthermore, the environmental impact of glass manufacturing, including energy consumption and waste generation, is under scrutiny, driving the need for more sustainable production practices and the adoption of recycled materials.
Emerging Opportunities in Europe Pharmaceutical Glass Vials And Ampoules Market
The Europe Pharmaceutical Glass Vials and Ampoules Market is ripe with emerging opportunities. The rapid growth of the biologics and biosimilars market presents a significant opportunity, as these complex drugs often require the inertness and stability of glass packaging. The increasing focus on personalized medicine and cell and gene therapies is creating demand for highly specialized, small-batch glass vials with unique specifications. Expansion into emerging European economies with growing healthcare sectors and increasing pharmaceutical manufacturing capabilities offers new market penetration avenues. Technological advancements in glass manufacturing, such as improved defect detection and enhanced surface treatments, can lead to premium product offerings and higher profit margins. The development of integrated packaging solutions, combining vials with specialized stoppers, syringes, and delivery devices, offers value-added opportunities. Furthermore, a stronger emphasis on sustainable packaging solutions, including the use of recycled glass and energy-efficient manufacturing processes, can provide a competitive edge and meet the growing environmental consciousness of pharmaceutical companies and consumers.
Leading Players in the Europe Pharmaceutical Glass Vials And Ampoules Market Market
- Scott Pharma (Scott AG)
- Gerresheimer AG
- Stevanato Group
- SGD S A
- DWK Life Sciences
- Bormioli Pharma S p A
- NAFVSM B V
- Soffieria Bertolini S p A
- SFAM Group
- Origin Pharma Packaging
- Alphial S r l
Key Developments in Europe Pharmaceutical Glass Vials And Ampoules Market Industry
- May 2024: Gerresheimer Glas GmbH, an indirect subsidiary of Gerresheimer AG, inked a purchase agreement with funds advised by Triton ("Triton") to acquire Blitz LuxCo Sarl, the holding entity of the Bormioli Pharma Group ("Bormioli Pharma"). The agreed purchase price hinges on an enterprise value pegged at approximately EUR 800 million (USD 883.24 million). Bormioli Pharma's diverse portfolio encompasses pharmaceutical primary packaging crafted from both glass and plastic, alongside closure solutions, accessories, and dispensing systems. Through this acquisition, Gerresheimer bolsters its presence in Europe, particularly in Southern regions, and solidifies its stature as a premier full-service provider and global ally to the pharmaceutical and biotech sectors.
- January 2024: SGD Pharma boosted capacity for siliconized glass vials with a new line. The company inaugurated a new siliconisation operation at its Saint-Quentin Lamotte (SQLM) facility in France. By bringing glass silicification in-house, the company bolsters its already comprehensive suite of services, ensuring quicker responses, a secure supply chain, and greater flexibility in vial sizes. The newly established operation at SQLM can handle all glass types, accommodating vial sizes from 3 ml to 500 ml in both clear and amber variants, all while maintaining a high processing capacity. This treatment caters to diverse market needs, including applications in anti-infectives, parenteral nutrition, diagnostics, animal health, and oncology.
Strategic Outlook for Europe Pharmaceutical Glass Vials And Ampoules Market Market
The strategic outlook for the Europe Pharmaceutical Glass Vials and Ampoules Market is highly positive, driven by the relentless innovation within the pharmaceutical sector and the indispensable role of high-quality primary packaging. Key growth catalysts include the expanding pipeline of injectable drugs, particularly in the biopharmaceutical and specialty medicine segments, which demand the superior barrier and inertness properties of glass. Investments in advanced manufacturing technologies, focusing on precision, sustainability, and integrated packaging solutions, will be crucial for market players to maintain a competitive edge. The increasing regulatory emphasis on drug safety and supply chain integrity further solidifies the demand for reliable glass packaging. Strategic partnerships and acquisitions, such as the Gerresheimer-Bormioli Pharma deal, are expected to continue shaping the market landscape by consolidating expertise and expanding service offerings. Opportunities lie in catering to the evolving needs of novel therapies like cell and gene therapies and in developing more sustainable and cost-effective manufacturing processes to address environmental concerns and raw material cost fluctuations. Overall, the market is poised for sustained growth, underscored by its critical contribution to global healthcare.
Europe Pharmaceutical Glass Vials And Ampoules Market Segmentation
-
1. Product Type
- 1.1. Vials
- 1.2. Ampoules
-
2. Geography***
- 2.1. Germany
- 2.2. Italy
- 2.3. France
- 2.4. United Kingdom
- 2.5. Spain
Europe Pharmaceutical Glass Vials And Ampoules Market Segmentation By Geography
- 1. Germany
- 2. Italy
- 3. France
- 4. United Kingdom
- 5. Spain
Europe Pharmaceutical Glass Vials And Ampoules Market Regional Market Share
Geographic Coverage of Europe Pharmaceutical Glass Vials And Ampoules Market
Europe Pharmaceutical Glass Vials And Ampoules Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 5.42% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Investments in Pharmaceutical Industry in the Region; The rising Trend of Sustainable Packaging Significant Growth Opportunities
- 3.3. Market Restrains
- 3.3.1. Investments in Pharmaceutical Industry in the Region; The rising Trend of Sustainable Packaging Significant Growth Opportunities
- 3.4. Market Trends
- 3.4.1. Ampoules Are Set To Hold Significant Market Share
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Europe Pharmaceutical Glass Vials And Ampoules Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Product Type
- 5.1.1. Vials
- 5.1.2. Ampoules
- 5.2. Market Analysis, Insights and Forecast - by Geography***
- 5.2.1. Germany
- 5.2.2. Italy
- 5.2.3. France
- 5.2.4. United Kingdom
- 5.2.5. Spain
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. Germany
- 5.3.2. Italy
- 5.3.3. France
- 5.3.4. United Kingdom
- 5.3.5. Spain
- 5.1. Market Analysis, Insights and Forecast - by Product Type
- 6. Germany Europe Pharmaceutical Glass Vials And Ampoules Market Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Product Type
- 6.1.1. Vials
- 6.1.2. Ampoules
- 6.2. Market Analysis, Insights and Forecast - by Geography***
- 6.2.1. Germany
- 6.2.2. Italy
- 6.2.3. France
- 6.2.4. United Kingdom
- 6.2.5. Spain
- 6.1. Market Analysis, Insights and Forecast - by Product Type
- 7. Italy Europe Pharmaceutical Glass Vials And Ampoules Market Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Product Type
- 7.1.1. Vials
- 7.1.2. Ampoules
- 7.2. Market Analysis, Insights and Forecast - by Geography***
- 7.2.1. Germany
- 7.2.2. Italy
- 7.2.3. France
- 7.2.4. United Kingdom
- 7.2.5. Spain
- 7.1. Market Analysis, Insights and Forecast - by Product Type
- 8. France Europe Pharmaceutical Glass Vials And Ampoules Market Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Product Type
- 8.1.1. Vials
- 8.1.2. Ampoules
- 8.2. Market Analysis, Insights and Forecast - by Geography***
- 8.2.1. Germany
- 8.2.2. Italy
- 8.2.3. France
- 8.2.4. United Kingdom
- 8.2.5. Spain
- 8.1. Market Analysis, Insights and Forecast - by Product Type
- 9. United Kingdom Europe Pharmaceutical Glass Vials And Ampoules Market Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Product Type
- 9.1.1. Vials
- 9.1.2. Ampoules
- 9.2. Market Analysis, Insights and Forecast - by Geography***
- 9.2.1. Germany
- 9.2.2. Italy
- 9.2.3. France
- 9.2.4. United Kingdom
- 9.2.5. Spain
- 9.1. Market Analysis, Insights and Forecast - by Product Type
- 10. Spain Europe Pharmaceutical Glass Vials And Ampoules Market Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Product Type
- 10.1.1. Vials
- 10.1.2. Ampoules
- 10.2. Market Analysis, Insights and Forecast - by Geography***
- 10.2.1. Germany
- 10.2.2. Italy
- 10.2.3. France
- 10.2.4. United Kingdom
- 10.2.5. Spain
- 10.1. Market Analysis, Insights and Forecast - by Product Type
- 11. Competitive Analysis
- 11.1. Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Scott Pharma (Scott AG)
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Gerresheimer AG
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Stevanato Group
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 SGD S A
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 DWK Life Sciences
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Bormioli Pharma S p A
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 NAFVSM B V
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Soffieria Bertolini S p A
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 SFAM Group
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Origin Pharma Packaging
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Alphial S r l *List Not Exhaustive 7 2 Heat Map Analysi
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.1 Scott Pharma (Scott AG)
List of Figures
- Figure 1: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Breakdown (Million, %) by Product 2025 & 2033
- Figure 2: Europe Pharmaceutical Glass Vials And Ampoules Market Share (%) by Company 2025
List of Tables
- Table 1: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Product Type 2020 & 2033
- Table 2: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Product Type 2020 & 2033
- Table 3: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Geography*** 2020 & 2033
- Table 4: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Geography*** 2020 & 2033
- Table 5: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Region 2020 & 2033
- Table 6: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Region 2020 & 2033
- Table 7: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Product Type 2020 & 2033
- Table 8: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Product Type 2020 & 2033
- Table 9: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Geography*** 2020 & 2033
- Table 10: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Geography*** 2020 & 2033
- Table 11: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Country 2020 & 2033
- Table 12: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Country 2020 & 2033
- Table 13: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Product Type 2020 & 2033
- Table 14: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Product Type 2020 & 2033
- Table 15: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Geography*** 2020 & 2033
- Table 16: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Geography*** 2020 & 2033
- Table 17: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Country 2020 & 2033
- Table 18: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Country 2020 & 2033
- Table 19: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Product Type 2020 & 2033
- Table 20: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Product Type 2020 & 2033
- Table 21: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Geography*** 2020 & 2033
- Table 22: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Geography*** 2020 & 2033
- Table 23: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Country 2020 & 2033
- Table 24: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Country 2020 & 2033
- Table 25: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Product Type 2020 & 2033
- Table 26: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Product Type 2020 & 2033
- Table 27: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Geography*** 2020 & 2033
- Table 28: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Geography*** 2020 & 2033
- Table 29: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Country 2020 & 2033
- Table 30: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Country 2020 & 2033
- Table 31: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Product Type 2020 & 2033
- Table 32: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Product Type 2020 & 2033
- Table 33: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Geography*** 2020 & 2033
- Table 34: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Geography*** 2020 & 2033
- Table 35: Europe Pharmaceutical Glass Vials And Ampoules Market Revenue Million Forecast, by Country 2020 & 2033
- Table 36: Europe Pharmaceutical Glass Vials And Ampoules Market Volume Billion Forecast, by Country 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe Pharmaceutical Glass Vials And Ampoules Market?
The projected CAGR is approximately 5.42%.
2. Which companies are prominent players in the Europe Pharmaceutical Glass Vials And Ampoules Market?
Key companies in the market include Scott Pharma (Scott AG), Gerresheimer AG, Stevanato Group, SGD S A, DWK Life Sciences, Bormioli Pharma S p A, NAFVSM B V, Soffieria Bertolini S p A, SFAM Group, Origin Pharma Packaging, Alphial S r l *List Not Exhaustive 7 2 Heat Map Analysi.
3. What are the main segments of the Europe Pharmaceutical Glass Vials And Ampoules Market?
The market segments include Product Type, Geography***.
4. Can you provide details about the market size?
The market size is estimated to be USD 0.8 Million as of 2022.
5. What are some drivers contributing to market growth?
Investments in Pharmaceutical Industry in the Region; The rising Trend of Sustainable Packaging Significant Growth Opportunities.
6. What are the notable trends driving market growth?
Ampoules Are Set To Hold Significant Market Share.
7. Are there any restraints impacting market growth?
Investments in Pharmaceutical Industry in the Region; The rising Trend of Sustainable Packaging Significant Growth Opportunities.
8. Can you provide examples of recent developments in the market?
May 2024: Gerresheimer Glas GmbH, an indirect subsidiary of Gerresheimer AG, inked a purchase agreement with funds advised by Triton ("Triton") to acquire Blitz LuxCo Sarl, the holding entity of the Bormioli Pharma Group ("Bormioli Pharma"). The agreed purchase price hinges on an enterprise value pegged at approximately EUR 800 million (USD 883.24 million). Bormioli Pharma's diverse portfolio encompasses pharmaceutical primary packaging crafted from both glass and plastic, alongside closure solutions, accessories, and dispensing systems. Through this acquisition, Gerresheimer bolsters its presence in Europe, particularly in Southern regions, and solidifies its stature as a premier full-service provider and global ally to the pharmaceutical and biotech sectors.January 2024: SGD Pharma boosted capacity for siliconized glass vials with a new line. The company inaugurated a new siliconisation operation at its Saint-Quentin Lamotte (SQLM) facility in France. By bringing glass silicification in-house, the company bolsters its already comprehensive suite of services, ensuring quicker responses, a secure supply chain, and greater flexibility in vial sizes. The newly established operation at SQLM can handle all glass types, accommodating vial sizes from 3 ml to 500 ml in both clear and amber variants, all while maintaining a high processing capacity. This treatment caters to diverse market needs, including applications in anti-infectives, parenteral nutrition, diagnostics, animal health, and oncology.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 4950, and USD 6800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in Billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Europe Pharmaceutical Glass Vials And Ampoules Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Europe Pharmaceutical Glass Vials And Ampoules Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Europe Pharmaceutical Glass Vials And Ampoules Market?
To stay informed about further developments, trends, and reports in the Europe Pharmaceutical Glass Vials And Ampoules Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence